ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 274 filers reported holding ALKERMES PLC in Q4 2022. The put-call ratio across all filers is 2.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,762,644 | -9.7% | 991,169 | +0.9% | 0.32% | -0.3% |
Q2 2023 | $30,755,913 | +110262.8% | 982,617 | -0.6% | 0.32% | +7.0% |
Q1 2023 | $27,868 | +108.6% | 988,587 | +93.4% | 0.30% | +102.0% |
Q4 2022 | $13,358 | -99.9% | 511,235 | +14.7% | 0.15% | +25.2% |
Q3 2022 | $9,952,000 | -22.5% | 445,667 | +3.4% | 0.12% | -17.9% |
Q2 2022 | $12,839,000 | +13.4% | 431,061 | +0.2% | 0.14% | +34.3% |
Q1 2022 | $11,322,000 | +13.6% | 430,296 | +0.4% | 0.11% | +17.4% |
Q4 2021 | $9,968,000 | -60.6% | 428,578 | -47.8% | 0.09% | -24.6% |
Q3 2021 | $25,326,000 | +156.6% | 821,094 | +104.1% | 0.12% | +27.1% |
Q2 2021 | $9,868,000 | +31.2% | 402,349 | -0.1% | 0.10% | +29.7% |
Q1 2021 | $7,521,000 | -6.6% | 402,793 | -0.2% | 0.07% | -17.8% |
Q4 2020 | $8,050,000 | +34.5% | 403,634 | +11.8% | 0.09% | +11.1% |
Q3 2020 | $5,983,000 | +40.7% | 361,061 | +64.9% | 0.08% | +14.1% |
Q2 2020 | $4,252,000 | +106.1% | 218,932 | +53.1% | 0.07% | +69.0% |
Q1 2020 | $2,063,000 | – | 143,031 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |